Playback speed
10 seconds
2021 Efficacy Data Review in Relapsed CLL: BTK Inhibitors, Ven+/-Rituximab, LOXO-305
By
8th Eurasian Hematology Oncology Summit
FEATURING
Susan O'Brien
By
8th Eurasian Hematology Oncology Summit
FEATURING
Susan O'Brien
136 views
June 11, 2021
Login to view comments.
Click here to Login